β-cell apoptosis in type 2 diabetes: quantitative and functional consequences
- 1 February 2008
- journal article
- review article
- Published by Elsevier in Diabetes & Metabolism
- Vol. 34, S56-S64
- https://doi.org/10.1016/s1262-3636(08)73396-2
Abstract
No abstract availableKeywords
This publication has 85 references indexed in Scilit:
- Glucolipotoxicity: Fuel Excess and β-Cell DysfunctionEndocrine Reviews, 2008
- Pancreatic islet dysfunction in type 2 diabetes: a rational target for incretin-based therapiesCurrent Medical Research and Opinion, 2007
- Different Mechanisms for Impaired Fasting Glucose and Impaired Postprandial Glucose Tolerance in HumansDiabetes Care, 2006
- New sources of pancreatic β-cellsNature Biotechnology, 2005
- Glucotoxicity and β-Cell Failure in Type 2 Diabetes MellitusJournal of Pediatric Endocrinology and Metabolism, 2003
- The Fas Signaling Pathway: More Than a ParadigmScience, 2002
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal.Journal of Clinical Investigation, 1994
- Effects of Hemipancreatectomy on Insulin Secretion and Glucose Tolerance in Healthy HumansNew England Journal of Medicine, 1990
- The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitusDiabetologia, 1978